EHC Investor News: If You Have Suffered Losses in Encompass Health Corporation (NYSE: EHC), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

EHC Investor News: If You Have Suffered Losses in Encompass Health Corporation (NYSE: EHC), You Are Encouraged to Contact The Rosen Law Firm About Your Rights GlobeNewswire September 25, 2025 NEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on […]

Golden Key Locksmith Delivers Emergency Locksmith Services in New York

New York, NY – In the heart of the city that never sleeps, Golden Key Locksmith emerges as a trusted leader in providing emergency locksmith new york services. Catering to the needs of New Yorkers around the clock, Golden Key Locksmith stands as a beacon of reliability and professionalism across the region’s locksmith industry. The

Did You Lose Money on Snap Inc. (SNAP)? Levi & Korsinsky Urges Investors to Act Before October 20, 2025

NEW YORK, NY / ACCESS Newswire / September 25, 2025 / If you suffered a loss on your Snap Inc. (NYSE:SNAP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/snap-inc-lawsuit-submission-form-2?prid=169438&wire=1&utm_campaign=28 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Disrupting Energy Waste: Charles Goetz Delivers Wireless Power at the Edge of AI

In a new Disruption Interruption episode, Powercast CEO Charles Goetz reveals how patented RF technology enables true wireless charging over distance. He discusses the environmental benefits of reducing battery waste and how this innovation will power the future of IoT and AI at the edge With studies warning that nearly 78 million IoT batteries could

Did You Lose Money on Snap Inc. (SNAP)? Levi & Korsinsky Urges Investors to Act Before October 20, 2025

NEW YORK, NY / ACCESS Newswire / September 25, 2025 / If you suffered a loss on your Snap Inc. (NYSE:SNAP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/snap-inc-lawsuit-submission-form-2?prid=169438&wire=1&utm_campaign=28 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

AbbVie’s Rinvoq Gains Early Traction in Giant Cell Arteritis Market, Expanding Options for Rheumatologists

EXTON, PA, Sept. 25, 2025 (GLOBE NEWSWIRE) — Rheumatologists report high satisfaction with AbbVie's Rinvoq (upadacitinib) following its recent approval in giant cell arteritis (GCA), with the majority citing anticipated efficacy, steroid-sparing benefits, and convenient oral administration as central drivers of adoption. Nearly all specialists are aware of the approval, and 40% have already prescribed

Bluerock Announces Shareholder Approval of Key Proposal in Connection with the Listing of the Bluerock Total Income+ Real Estate Fund on the New York Stock Exchange

Bluerock is pleased to announce shareholder approval of a key proposal in connection with the listing of the Bluerock Total Income+ Real Estate Fund (“TI+” or the “Fund”) on the New York Stock Exchange. The proposal1, recommended by independent proxy advisory firms Institutional Shareholder Services Inc. and Glass Lewis & Co. and the Fund's Board

AbbVie’s Rinvoq Gains Early Traction in Giant Cell Arteritis Market, Expanding Options for Rheumatologists

AbbVie's Rinvoq Gains Early Traction in Giant Cell Arteritis Market, Expanding Options for Rheumatologists Spherix Global Insights finds majority of specialists expect Rinvoq's uptake to accelerate, with potential implications branching to the polymyalgia rheumatica landscape. GlobeNewswire September 25, 2025 EXTON, PA, Sept. 25, 2025 (GLOBE NEWSWIRE) — Rheumatologists report high satisfaction with AbbVie's Rinvoq (upadacitinib)

Scroll to Top